Top Markets
#1 ADO Protocol ADO Protocol +193.34%
#2 Islamic Coin Islamic Coin +155.37%
#3 GoPlus Security GoPlus Security +44.27%
#4 GAIB AID GAIB AID +24.67%
#5 SkyAI SkyAI +14.39%
#6 Verus Coin Verus Coin +13.64%
#7 o1.exchange o1.exchange +12.48%
#8 Tutorial Tutorial +12.27%
#9 Casper Network Casper Network +12.23%
#10 Pons Pons +12.22%
Coin of the day
ADO Protocol ADO Protocol
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Kedudukan dalam Saham #33732
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Harga Saham
$4.58
Disegerakkan terakhir: 2025-05-09
Modal Pasaran
$6.98M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan NeuroMetrix, Inc. (NURO)

Kategori

Healthcare
Pendapatan untuk NeuroMetrix, Inc. (NURO)
Pendapatan pada Dec 2024 TTM: $-7.81M
Menurut laporan kewangan terkini NeuroMetrix, Inc., pendapatan semasa syarikat ialah $-7.81M. Pada tahun 2023, syarikat memperoleh pendapatan sebanyak $-6.53M, penurunan berbanding pendapatan pada tahun 2022 yang berjumlah $-4.42M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi NeuroMetrix, Inc. dari 2001 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
2026 (TTM) $-7.81M 0.00%
2024 $-7.81M 19.55%
2023 $-6.53M 47.84%
2022 $-4.42M 93.58%
2021 $-2.28M 9.05%
2020 $-2.09M -44.55%
2019 $-3.77M -16,083.96%
2018 $23.61K -100.18%
2017 $-12.86M -13.77%
2016 $-14.91M 62.32%
2015 $-9.19M 18.30%
2014 $-7.77M -3.15%
2013 $-8.02M -19.87%
2012 $-10.01M 0.26%
2011 $-9.98M -41.33%
2010 $-17.01M -99.86%
2009 $-11.92B 56,302.52%
2008 $-21.13M 152.19%
2007 $-8.38M -287.82%
2006 $4.46M 358.34%
2005 $973.26K -100.01%
2004 $-13.51B 0.00%
2003 0.00 0.00%
2002 0.00 0.00%
2001 0.00 0.00%
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -96,320.18%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -66,048.81%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -71,365.19%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -49,561.60%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -18,260.26%
US